Merus BV (MRUS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec23

Genmab A/S Acquires Merus Shares Leading to Executive Changes

03:26

Dec22

Genmab A/S Acquires Additional Ordinary Shares in Merus NV

22:16

Dec12

Genmab Completes Acquisition of Merus N.V. for $97 per Share

06:35

Nov17

Merus N.V. Signs Non-exclusive Collaboration and License Agreement with Halozyme Therapeutics

13:18

Nov12

Merus N.V. to Hold Extraordinary Shareholders Meeting to Consider Genmab Acquisition Proposal

13:48

Nov10

Genmab A/S plans to issue notes and launch loans to raise funds for acquisition of Merus

12:16

Schedules & Filings

Schedules

Filings

Oct31

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.15 M, Net Income -95.52 M, EPS -1.2622

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 8.828 M, Net Income -158.22 M, EPS -2.2253

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 26.49 M, Net Income -96.47 M, EPS -1.3978

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change